FindTrial
Sign In

A real-world cohort study of the entire growth and development cycle of children: analysis of the long-term safety and key factors of rhGH based on a multicenter long-term follow-up database

A real-world cohort study of the entire growth and development cycle of children: analysis of the long-term safety and key factors of rhGH based on a multicenter long-term follow-up database

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122455
Enrollment
Unknown
Registered
2026-04-14
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth retardation

Interventions

GH treatment group:None
Non-GH treatment group:None

Sponsors

The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.GH-treated group: children who had received LA-rhGH or rhGH treatment before signing informed consent; 2.GH-non-treated group: children who had not received LA-rhGH or rhGH treatment; LA-rhGH or rhGH treatment duration was less than 3 months;

Exclusion criteria

Exclusion criteria: 1.Any other circumstances that the researcher deems unsuitable for the study;

Design outcomes

Primary

MeasureTime frame
GH medication record;Changes in height standard deviation score before and after treatment (?Ht SDS);Growth Velocity(GV);Final height;Living quality;—

Secondary

MeasureTime frame
Weight;Bone age;Genetic results;Tanner staging;Incidence of drug-related adverse events;All due to the incidence of adverse reactions;—

Countries

China

Contacts

Public ContactWang Chunlin

The FIrst Affiliated Hospital, College of Medicine, Zhejiang University

hzwangcl@zju.edu.cn+86 13777442850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026